Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 7.86
-0.46 (-5.53%)
Oct 14, 2026, 4:24 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 68.52 million as of October 14, 2026. It is the 43,350th most valuable company in the world and the 641st biggest in Sweden. Its market cap has decreased by 64.05% in one year.
Market Cap
68.52M
Enterprise Value
63.25M
Revenue
n/a
Global Rank
Country Rank
#641 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 68.52M, an increase of 36.48%. That is a compound annual growth rate of 3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 68.52M | -50.97% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 128.69M |
| NextCell Pharma AB | 127.66M |
| OncoZenge AB | 107.23M |
| Active Biotech AB | 92.39M |
| Nanologica AB | 87.78M |
| Ascelia Pharma AB | 86.93M |
| Biovica International AB | 86.41M |
| Spago Nanomedical AB | 81.04M |